|
1
|
Patrick RJ, Fenske NA and Messina JL:
Primary mucosal melanoma. J Am Acad Dermatol. 56:828–834. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tacastacas JD, Bray J, Cohen YK, Arbesman
J, Kim J, Koon HB, Honda K, Cooper KD and Gerstenblith MR: Update
on primary mucosal melanoma. J Am Acad Dermatol. 71:366–375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gru AA, Becker N, Dehner LP and Pfeifer
JD: Mucosal melanoma: Correlation of clinicopathologic, prognostic,
and molecular features. Melanoma Res. 24:360–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thierauf J, Veit JA, Affolter A, Bergmann
C, Grünow J, Laban S, Lennerz JK, Grünmüller L, Mauch C, Plinkert
PK, et al: Identification and clinical relevance of PD-L1
expression in primary mucosal malignant melanoma of the head and
neck. Melanoma Res. 25:503–509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ragnarsson-Olding BK, Karsberg S, Platz A
and Ringborg UK: Mutations in the TP53 gene in human malignant
melanomas derived from sun-exposed skin and unexposed mucosal
membranes. Melanoma Res. 12:453–463. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu W, Li S, Zou B, Liu H and Wang S:
Expressions and clinical significance of HER4 and CD44 in sinonasal
mucosal malignant melanoma. Melanoma Res. 28:105–110. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SY, Kim SN, Hahn HJ, Lee YW, Choe YB
and Ahn KJ: Metaanalysis of BRAF mutations and clinicopathologic
characteristics in primary melanoma. J Am Acad Dermatol.
72:1036–46.e2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8:162007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stroup DF, Berlin JA, Morton SC, Olkin I,
Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker
SB: Meta-analysis of observational studies in epidemiology: A
proposal for reporting. Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. PLoS Med.
6:e10000972009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ohashi A, Funasaka Y, Ueda M and Ichihashi
M: c-KIT receptor expression in cutaneous malignant melanoma and
benign melanotic naevi. Melanoma Res. 6:25–30. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Postow MA, Hamid O and Carvajal RD:
Mucosal melanoma: Pathogenesis, clinical behavior, and management.
Curr Oncol Rep. 14:441–448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Altieri L, Wong MK, Peng DH and Cockburn
M: Mucosal melanomas in the racially diverse population of
California. J Am Acad Dermatol. 76:250–257. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luna-Ortiz K, Aguilar-Romero M,
Villavicencio-Valencia V, Zepeda-Castilla E, Vidrio-Morgado H,
Peteuil N and Mosqueda-Taylor A: Comparative study between two
different staging systems for mucosal melanomas of the Head and
Neck. Med Oral Patol Oral Cir Bucal. 21:e425–e430. 2016.PubMed/NCBI
|
|
15
|
Youssef D, Vasani S, Marquess J and Cervin
A: Rising incidence of head and neck mucosal melanoma in Australia.
J Laryngol Otol. 131:S25–S28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marcus DM, Marcus RP, Prabhu RS, Owonikoko
TK, Lawson DH, Switchenko J and Beitler JJ: Rising incidence of
mucosal melanoma of the head and neck in the United States. J Skin
Cancer. 2012:2316932012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abugideiri M, Patel K, Switchenko JM,
Magliocca K, Buchwald ZS, Delgaudio J, Beitler JJ and Khan MK:
Adjuvant radiation therapy improved local control for primary
mucosal melanoma of the head and neck. Int J Radiation Oncol.
96:E384–E385. 2016. View Article : Google Scholar
|
|
18
|
Ahn HJ, Na II, Park YH, Cho SY, Lee BC,
Lee GH, Koh JS, Lee YS, Shim YS, Kim YK, et al: Role of adjuvant
chemotherapy in malignant mucosal melanoma of the head and neck.
Oral Oncol. 46:607–611. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aiempanakit K, Chiratikarnwong K,
Auepemkiate S and Sriplung H: Clinicopathologic characteristics and
survival outcomes of primary mucosal melanomas: A 10-year
retrospective analysis from a single tertiary medical center in
Thailand. Zhonghua Pifuke Yixue Zazhi xxx. 1–3. 2018.
|
|
20
|
Ajmani GS, Liederbach E, Kyrillos A, Wang
CH, Pinto JM and Bhayani MK: Adjuvant radiation and survival
following surgical resection of sinonasal melanoma. Am J
Otolaryngol. 38:663–667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amit M, Tam S, Abdelmeguid AS, Roberts DB,
Raza SM, Su SY, Kupferman ME, DeMonte F and Hanna EY: Approaches to
regional lymph node metastasis in patients with head and neck
mucosal melanoma. Cancer. 124:514–520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Angelo SP, Larkin J, Sosman JA, Lebbé C,
Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, et al:
Efficacy and safety of nivolumab alone or in combination with
ipilimumab in patients with mucosal melanoma: A pooled analysis. J
Clin Oncol. 35:226–235. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benlyazid A, Thariat J, Temam S, Malard O,
Florescu C, Choussy O, Makeieff M, Poissonnet G, Penel N, Righini
C, et al: Postoperative radiotherapy in head and neck mucosal
melanoma: A GETTEC study. Arch Otolaryngol Head Neck Surg.
136:1219–1225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bishop KD and Olszewski AJ: Epidemiology
and survival outcomes of ocular and mucosal melanomas: A
population-based analysis. Int J Cancer. 134:2961–2971. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chiu NT and Weinstock MA: Melanoma of
oronasal mucosa. Population-based analysis of occurrence and
mortality. Arch Otolaryngol Head Neck Surg. 122:985–988. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ciarrocchi A, Pietroletti R, Carlei F and
Amicucci G: Extensive surgery and lymphadenectomy do not improve
survival in primary melanoma of the anorectum: Results from
analysis of a large database (SEER). Colorectal Dis. 19:158–164.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ercelep O, Topcu TO, Bayoglu IV, Ekinci
AS, Koca S, Kavgaci H, Ozcelik M, Alacacioglu A, Uzunoglu S,
Bozkurt O, et al: Retrospective multicenter evaluation of patients
diagnosed with mucosal melanoma: A study of Anatolian Society of
Medical Oncology. Tumour Biol. 37:12033–12038. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harada K, Mine S, Yamada K, Shigaki H, Oya
S, Baba H and Watanabe M: Long-term outcome of esophagectomy for
primary malignant melanoma of the esophagus: A single-institute
retrospective analysis. Dis Esophagus. 29:314–319. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hasebe M, Yoshikawa K, Nishii R, Kawaguchi
K, Kamada T and Hamada Y: Usefulness of 11C-methionine-PET for
predicting the efficacy of carbon ion radiation therapy for head
and neck mucosal malignant melanoma. Int J Oral Maxillofac Surg.
46:1220–1228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Heinzelmann-Schwarz VA, Nixdorf S, Valadan
M, Diczbalis M, Olivier J, Otton G, Fedier A, Hacker NF and Scurry
JP: A clinicopathological review of 33 patients with vulvar
melanoma identifies c-KIT as a prognostic marker. Int J Mol Med.
33:784–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heppt MV, Roesch A, Weide B, Gutzmer R,
Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff
D, et al: Prognostic factors and treatment outcomes in 444 patients
with mucosal melanoma. Eur J Cancer. 81:36–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hughes MC, Wright A, Barbour A, Thomas J,
Smithers BM, Green AC and Khosrotehrani K: Patients undergoing
lymphadenectomy for stage III melanomas of known or unknown primary
site do not differ in outcome. Int J Cancer. 133:3000–3007.
2013.PubMed/NCBI
|
|
33
|
Jang HS, Kim JH, Park KH, Lee JS, Bae JM,
Oh BH, Rha SY, Roh MR and Chung KY: Comparison of melanoma subtypes
among Korean patients by morphologic features and ultraviolet
exposure. Ann Dermatol. 26:485–490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang X, Zeng Y, Liang J, Li J, Ren D, Chai
L, Sun Z, Yu S, Wu X, Han W, et al: Aberrations and clinical
significance of BRAF in malignant melanoma: A series of 60 cases in
Chinese Uyghur. Medicine (Baltimore). 97:e95092018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khan MN, Kanumuri VV, Raikundalia MD,
Vazquez A, Govindaraj S, Baredes S and Eloy JA: Sinonasal melanoma:
Survival and prognostic implications based on site of involvement.
Int Forum Allergy Rhinol. 4:151–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kirchoff DD, Deutsch GB, Foshag LJ, Lee
JH, Sim MS and Faries MB: Evolving Therapeutic Strategies in
Mucosal Melanoma Have Not Improved Survival Over Five Decades. Am
Surg. 82:1–5. 2016.PubMed/NCBI
|
|
37
|
Kirschner AN, Kidd EA, Dewees T and
Perkins SM: Treatment approach and outcomes of vaginal melanoma.
Int J Gynecol Cancer. 23:1484–1489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kong Y, Si L, Li Y, Wu X, Xu X, Dai J,
Tang H, Ma M, Chi Z, Sheng X, et al: Analysis of mTOR Gene
Aberrations in Melanoma Patients and Evaluation of Their
Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors. Clin Cancer Res.
22:1018–1027. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Konuthula N, Khan MN, Parasher A, Del
Signore A, Genden EM, Govindaraj S and Iloreta AM: The presentation
and outcomes of mucosal melanoma in 695 patients. Int Forum Allergy
Rhinol. 7:99–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Koto M, Demizu Y, Saitoh JI, Suefuji H,
Tsuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Nemoto K, et al
Japan Carbon-Ion Radiation Oncology Study Group, : Multicenter
study of carbon-ion radiation therapy for mucosal melanoma of the
head and neck: Subanalysis of the Japan Carbon-Ion Radiation
Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol
Biol Phys. 97:1054–1060. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kuk SK, Won CH, Lee WJ, Shin WJ, Yoon HJ,
Hong SD, Hong SP and Lee J: Prognostic significance of nestin in
primary malignant melanoma of the oral cavity. Melanoma Res.
26:457–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lansu J, Klop WM, Heemsbergen W, Navran A,
Al-Mamgani A, Langendijk JA, Kaanders JH, Terhaard C, Karakullukcu
B and Hamming-Vrieze O: Local control in sinonasal malignant
melanoma: Comparing conventional to hypofractionated radiotherapy.
Head Neck. 40:86–93. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lawaetz M, Birch-Johansen F, Friis S,
Eriksen JG, Kiss K, Gade S, Møller-Madsen M, Pourbordbari N and von
Buchwald C: Primary mucosal melanoma of the head and neck in
Denmark, 1982–2012: Demographic and clinical aspects. A
retrospective DAHANCA study. Acta Oncol. 55:1001–1008. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee G, Baek CH, Choi NY and Chung MK: The
prognostic role of the surgical approach and adjuvant therapy in
operable mucosal melanoma of the head and neck. Clin Exp
Otorhinolaryngol. 10:97–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee RJ, Lee SA, Lin T, Lee KK and
Christensen RE: Determining the epidemiologic, outcome, and
prognostic factors of oral malignant melanoma by using the
Surveillance, Epidemiology, and End Results database. J Am Dent
Assoc. 148:288–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lombardi D, Bottazzoli M, Turri-Zanoni M,
Raffetti E, Villaret AB, Morassi ML, Ungari M, Vermi W, Battaglia
P, Castelnuovo P, et al: Sinonasal mucosal melanoma: A 12-year
experience of 58 cases. Head Neck. 38 (Suppl 1):E1737–E1745. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mücke T, Hölzle F, Kesting MR, Loeffelbein
DJ, Robitzky LK, Hohlweg-Majert B, Tannapfel A and Wolff KD: Tumor
size and depth in primary malignant melanoma in the oral cavity
influences survival. J Oral Maxillofac Surg. 67:1409–1415. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nakamura Y, Fujisawa Y, Tanaka R, Maruyama
H, Ishitsuka Y, Okiyama N, Watanabe R and Fujimoto M: Use of immune
checkpoint inhibitors prolonged overall survival in a Japanese
population of advanced malignant melanoma patients: Retrospective
single institutional study. J Dermatol. 45:1337–1339. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Oba J, Nakahara T, Abe T, Hagihara A,
Moroi Y and Furue M: Expression of c-Kit, p-ERK and cyclin D1 in
malignant melanoma: An immunohistochemical study and analysis of
prognostic value. J Dermatol Sci. 62:116–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pandey M, Mathew A, Iype EM, Sebastian P,
Abraham EK and Nair KM: Primary malignant mucosal melanoma of the
head and neck region: Pooled analysis of 60 published cases from
India and review of literature. Eur J Cancer Prev. 11:3–10. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pfeil AF, Leiter U, Buettner PG, Eigentler
TK, Weide B, Meier F and Garbe C: Melanoma of unknown primary is
correctly classified by the AJCC melanoma classification from 2009.
Melanoma Res. 21:228–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Plavc G, But-Hadžić J, Aničin A, Lanišnik
B, Didanović V and Strojan P: Mucosal melanoma of the head and
neck: A population-based study from Slovenia, 1985–2013. Radiat
Oncol. 11:1372016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Roh MR, Gupta S, Park KH, Chung KY, Lauss
M, Flaherty KT, Jönsson G, Rha SY and Tsao H: Promoter Methylation
of PTEN Is a Significant Prognostic Factor in Melanoma Survival. J
Invest Dermatol. 136:1002–1011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Samstein RM, Carvajal RD, Postow MA,
Callahan MK, Shoushtari AN, Patel SG, Lee NY and Barker CA:
Localized sinonasal mucosal melanoma: Outcomes and associations
with stage, radiotherapy, and positron emission tomography
response. Head Neck. 38:1310–1317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sanchez A, Rodríguez D, Allard CB, Bechis
SK, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW,
Preston MA, et al: Primary genitourinary melanoma: Epidemiology and
disease-specific survival in a large population-based cohort. Urol
Oncol. 34:166.e7–166.e14. 2016. View Article : Google Scholar
|
|
56
|
Schaefer T, Satzger I and Gutzmer R:
Clinics, prognosis and new therapeutic options in patients with
mucosal melanoma: A retrospective analysis of 75 patients. Medicine
(Baltimore). 96:e57532017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Schmidt MQ, David J, Yoshida EJ, Scher K,
Mita A, Shiao SL, Ho AS and Zumsteg ZS: Predictors of survival in
head and neck mucosal melanoma. Oral Oncol. 73:36–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shoushtari AN, Bluth MJ, Goldman DA, Bitas
C, Lefkowitz RA, Postow MA, Munhoz RR, Buchar G, Hester RH, Romero
JA, et al: Clinical features and response to systemic therapy in a
historical cohort of advanced or unresectable mucosal melanoma.
Melanoma Res. 27:57–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shuman AG, Light E, Olsen SH, Pynnonen MA,
Taylor JM, Johnson TM and Bradford CR: Mucosal melanoma of the head
and neck: Predictors of prognosis. Arch Otolaryngol Head Neck Surg.
137:331–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Song H, Jing G, Wang L, Guo W and Ren G:
Periodic acid-Schiff-positive loops and networks as a prognostic
factor in oral mucosal melanoma. Melanoma Res. 26:145–152. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sun CZ, Li QL, Hu ZD, Jiang YE, Song M and
Yang AK: Treatment and prognosis in sinonasal mucosal melanoma: A
retrospective analysis of 65 patients from a single cancer center.
Head Neck. 36:675–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tchelebi L, Guirguis A and Ashamalla H:
Rectal melanoma: Epidemiology, prognosis, and role of adjuvant
radiation therapy. J Cancer Res Clin Oncol. 142:2569–2575. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Thariat J, Poissonnet G, Marcy PY, Lattes
L, Butori C, Guevara N, Dassonville O, Santini J, Bensadoun RJ and
Castillo L: Effect of surgical modality and hypofractionated
split-course radiotherapy on local control and survival from
sinonasal mucosal melanoma. Clin Oncol (R Coll Radiol). 23:579–586.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang X, Wen W, Wu H, Chen Y, Ren G and Guo
W: Heparanase expression correlates with poor survival in oral
mucosal melanoma. Med Oncol. 30:6332013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wen X, Ding Y, Li J, Zhao J, Peng R, Li D,
Zhu B, Wang Y and Zhang X and Zhang X: The experience of immune
checkpoint inhibitors in Chinese patients with metastatic melanoma:
A retrospective case series. Cancer Immunol Immunother.
66:1153–1162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Won TB, Choi KY, Rhee CS, Jin HR, Yi JS,
Dhong HJ, Kim SW, Choi JH, Kim JK, Chung YJ, et al: Treatment
outcomes of sinonasal malignant melanoma: A Korean multicenter
study. Int Forum Allergy Rhinol. 5:950–959. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yeh JJ, Shia J, Hwu WJ, Busam KJ, Paty PB,
Guillem JG, Coit DG, Wong WD and Weiser MR: The role of
abdominoperineal resection as surgical therapy for anorectal
melanoma. Ann Surg. 244:1012–1017. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yi JH, Yi SY, Lee HR, Lee SI, Lim DH, Kim
JH, Park KW and Lee J: Dacarbazine-based chemotherapy as first-line
treatment in noncutaneous metastatic melanoma: Multicenter,
retrospective analysis in Asia. Melanoma Res. 21:223–227. 2011.
View Article : Google Scholar : PubMed/NCBI
|
